PPHM

Peregrine Pharmaceuticals to Report Third Quarter Fiscal Year 2014 Financial Results Before Market Open on March 7, 2014

[Marketwired] – Peregrine Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced that it will … moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option in Connection With Preferred Stock Offering

[Marketwired] – Peregrine Pharmaceuticals, Inc. , announced today that the underwriters of its underwritten public offering of its 10.50% Series E Convertible Preferred Stock have partially exercised their option to cover … moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option in Connection With Preferred Stock Offering

[Marketwired] – Peregrine Pharmaceuticals, Inc. , announced today that the underwriters of its underwritten public offering of its 10.50% Series E Convertible Preferred Stock have partially exercised their option to cover … moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]